XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statement of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain ( Loss)
Accumulated Deficit
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022   28,513,000      
Stockholders' equity, beginning balance at Dec. 31, 2022 $ 262,103 $ 29 $ 717,797 $ (5,246) $ (450,477)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   55,000      
Issuance of common stock from exercises of options and employee stock purchase plan 1,222   1,222    
Issuance of common stock upon vesting of restricted stock units (in shares)   39,000      
Repurchases and retirements of common stock (in shares)   (1,589,000)      
Repurchases and retirements of common stock (38,816) $ (2) (38,814)    
Stock-based compensation 8,860   8,860    
Comprehensive gain (loss), net 1,979     1,979  
Net loss (44,255)       (44,255)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2023   27,018,000      
Stockholders' equity, ending balance at Mar. 31, 2023 191,093 $ 27 689,065 (3,267) (494,732)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2022   28,513,000      
Stockholders' equity, beginning balance at Dec. 31, 2022 262,103 $ 29 717,797 (5,246) (450,477)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (121,408)        
Stockholders' equity, ending balance (in shares) at Sep. 30, 2023   26,575,000      
Stockholders' equity, ending balance at Sep. 30, 2023 120,383 $ 27 694,591 (2,350) (571,885)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2023   27,018,000      
Stockholders' equity, beginning balance at Mar. 31, 2023 191,093 $ 27 689,065 (3,267) (494,732)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   48,000      
Issuance of common stock from exercises of options and employee stock purchase plan 775   775    
Repurchases and retirements of common stock (in shares)   (535,000)      
Repurchases and retirements of common stock (11,656)   (11,656)    
Stock-based compensation 8,427   8,427    
Comprehensive gain (loss), net (344)     (344)  
Net loss (39,845)       (39,845)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2023   26,531,000      
Stockholders' equity, ending balance at Jun. 30, 2023 148,450 $ 27 686,611 (3,611) (534,577)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   14,000      
Issuance of common stock from exercises of options and employee stock purchase plan 160   160    
Issuance of common stock upon vesting of restricted stock units (in shares)   30,000      
Repurchases and retirements of common stock 13   13    
Stock-based compensation 7,807   7,807    
Comprehensive gain (loss), net 1,261     1,261  
Net loss (37,308)       (37,308)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2023   26,575,000      
Stockholders' equity, ending balance at Sep. 30, 2023 $ 120,383 $ 27 694,591 (2,350) (571,885)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023 26,597,000 26,597,000      
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 88,103 $ 27 702,969 (797) (614,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   53,000      
Issuance of common stock from exercises of options and employee stock purchase plan 811   811    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,014,000      
Net share settlement of restricted stock units (in shares)   (347,000)      
Net share settlement of restricted stock units (7,504)   (7,504)    
Stock-based compensation 10,131   10,131    
Comprehensive gain (loss), net 173     173  
Net loss (43,936)       (43,936)
Stockholders' equity, ending balance (in shares) at Mar. 31, 2024   27,317,000      
Stockholders' equity, ending balance at Mar. 31, 2024 $ 47,778 $ 27 706,407 (624) (658,032)
Stockholders' equity, beginning balance (in shares) at Dec. 31, 2023 26,597,000 26,597,000      
Stockholders' equity, beginning balance at Dec. 31, 2023 $ 88,103 $ 27 702,969 (797) (614,096)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss $ (123,447)        
Stockholders' equity, ending balance (in shares) at Sep. 30, 2024 30,428,682 30,429,000      
Stockholders' equity, ending balance at Sep. 30, 2024 $ 84,367 $ 30 821,121 759 (737,543)
Stockholders' equity, beginning balance (in shares) at Mar. 31, 2024   27,317,000      
Stockholders' equity, beginning balance at Mar. 31, 2024 47,778 $ 27 706,407 (624) (658,032)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   75,000      
Issuance of common stock from exercises of options and employee stock purchase plan 1,008   1,008    
Issuance of common stock upon vesting of restricted stock units (in shares)   42,000      
Stock-based compensation 7,544   7,544    
Comprehensive gain (loss), net 209     209  
Net loss (46,660)       (46,660)
Stockholders' equity, ending balance (in shares) at Jun. 30, 2024   27,434,000      
Stockholders' equity, ending balance at Jun. 30, 2024 9,879 $ 27 714,959 (415) (704,692)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock from exercises of options and employee stock purchase plan (in shares)   196,000      
Issuance of common stock from exercises of options and employee stock purchase plan 4,099   4,099    
Issuance of common stock upon vesting of restricted stock units (in shares)   48,000      
Issuance of common stock from registered direct offering (in shares)   2,751,000      
Issuance of common stock, net of $6,516 of transaction costs 93,877 $ 3   93,874  
Stock-based compensation 8,189   8,189    
Comprehensive gain (loss), net 1,174     1,174  
Net loss $ (32,851)       (32,851)
Stockholders' equity, ending balance (in shares) at Sep. 30, 2024 30,428,682 30,429,000      
Stockholders' equity, ending balance at Sep. 30, 2024 $ 84,367 $ 30 $ 821,121 $ 759 $ (737,543)